Search
|
Browse
|
Subscribe
|
Access Account
Retrieve Order
About Us
Contact Us
Retailnet RSS feeds
Sitemap
|
Now Available:
- Relevant digital packages (PDF files) ready for download.
- Custom news alerts and e-newsletters via email (you specify the companies to monitor).
- Full text search 60,000+ documents from the archives of 5 major retailing print publications.
- Retail headlines updated throughout the entire business day.
- Current news and financial information on hundreds of companies in Retail.
Coming Soon:
- Discussion forums for Retail executives (read and post to various topic threads).
- Digital "full access" subscriptions to all of our premium content.
Retail Clinician EXCLUSIVE: Take Care/Gallup Patient Engagement study
In today's consumer-driven healthcare environment, simply satisfying a patient is not enough; patients want to feel a personal connection. They want to be engaged. This fact has not gone unnoticed at Take Care Health Systems and, judging by the results of a recent Gallup survey, the clinic operator is taking the patient experience to a whole new level and paving the way for improved patient outcomes. How? It's all in the secret sauce.
Click here to download the free PDF of Retail Clinician EXCLUSIVE: Take Care/Gallup Patient Engagement study.
PDF Format: 1 file, 5 pages
Price: $0.00
|
|
Special Report:Walgreens
Walgreens’ management and shareholders were long accustomed to steady, record-breaking gains in sales and earnings and a pedal-to-the-metal store-development strategy that made Walgreens the nation¹s fastest-growing pharmacy retailer and a market leader in cities across the country. But today the crown jewel of chain drug store retailing is struggling with a scary economic outlook, a consumer afraid to open her wallet, and a new breed of integrated health care retailer, exemplified by the company¹s arch-rival, CVS Caremark, that blends the customer drawing power and data-generating abilities of thousands of stores with the market-moving clout of a massive pharmacy benefit management capability.
Anchored by an exclusive interview with new CEO Greg Wasson, this special report examines what Walgreens is doing to recapture its mojo, bringing its cost structure in line with current sales trends through a new "More from the Core" operating strategy and targeting new growth opportunities through a program it calls "Complete Health and Wellness," which targets reduced healthcare and prescription costs for bug healthcare payers
PDF Format: 1 File, 13pages
Price: $19.99
|
|
Special Report: Regional Chains
So what do boxing and retail pharmacy have in common? More than you might think. Like boxers in the ring, both regional and national players are battling for the win and striving to overcome much of the same challenges, whether it is an uppercut from average wholesale price, a jab from patients coping with rising pharmacy premiums and co-pays, or a counterpunch from the rival down the street. But despite the challenges and added pressure from retail heavyweights, regional players refuse to get pinned against the ropes.
PDF Format: 1 file, 7pages
Price: $9.99
|
|
Special Report: Generic Drugs
Generic drug makers depend on a steady supply of expiring patents coming from large pharmaceutical companies for their business. In recent years, a whole slew of blockbuster drugs have come off patent, allowing generic drug makers to lap up the drug compounds. Over the next several years, however, the supply of expiring patents will begin to run dry. Between this year and 2016, $131 billion worth of drugs will come off patent, followed by a long decline often called the patent cliff. Facing this precipice, generic drug companies will have to adapt as the market becomes increasingly commoditized.
PDF Format:9-page report
Price: $19.99
|
|
New Age Buying Incentives
What will it take to turn consumers into buyers during these difficult economic times?
A September 2008 study by Chain Store Age and Leo J. Shapiro & Associates of 21 different incentives reveals which ones are most effective at stimulating retail sales.
The new study, “New Age Buying Incentives,” is based on interviews with 800 households in 36 states representing 83% of the U.S. household population.
Incentives studied included promises of savings and service. Many consumers have been forced to rely on opportunities to save money to maintain their standard of living. The findings of this study demonstrate what is now at stake in retail promotional programs and, more importantly, can assist retailers and vendors in designing programs that are likely to achieve a competitive edge.
The study separates customer incentives for small and big ticket purchases.
Also measured were consumer responses to different media.
PDF format. 82-page report.
Price: $990.00
|
|
Special Report:Walmart RX FOR AN UPGRADE
The pharmacy at Wal-Mart is in for some major changes in the coming years as the retailer looks to upgrade its prescription drug departments in keeping with a broader strategy to make the customer experience at its stores fast, clean and friendly.
Such attributes have not historically been associated with shopping at Wal-Mart, but the company set out to change that perception in late 2005 when it embarked on a sweeping three-year transformation plan. There were lots of changes among senior personnel and the structure of such groups as merchandising, marketing and operations, but what customers noticed most was the arrival of new brands throughout the store, shorter checkout lines, less clutter as inventory was eliminated and a new advertising slogan that touted, “Save money. Live better.”
PDF Format:1 file, 4 pages
Price: $9.99
|
|
Special Report: 2008 Generics Report
The 1840s had the California Gold Rush. The 1990s had the tech boom. Years from now, historians might label the early 2000s the generic drugs rush.
But whatever they call it, the big growth years may be behind the generic drug industry. In fact, some believe that over the course of the next five years or so, the boom even could go bust, as a shortage of big blockbuster drug launches today means a dropoff in the number of new generic introductions tomorrow. In this special report, Drug Store News examines the state of the generics industry and where it’s going
PDF Format: 7page, 1 file
Price: $19.99
|
|
Special Report:Rite Aid Annual
Rite Aid began posting same-store sales results across its acquired Brooks/Eckerd store base in June, and already the chain is painting a more rosy picture. Rite Aid’s July comp results were well ahead of several analyst expectations. In this special report, Drug Store News examines the third-largest retail pharmacy chain.
PDF Format: 6 page, 1 file
Price: $19.99
|
|
Special Report: Annual Rx 2008
After a monumental effort to educate lawmakers about the value of community pharmacy and the dangers the industry faces from new Medicaid reimbursement rules and other regulatory threats, the nation's pharmacy leaders won a landmark victory last month when the Medicare Improvements for Patients and Providers Act of 2008 became law, despite opposition from the Bush White House. Nevertheless, there's not much time for celebration. New challenges are waiting.
PDF Format. 33-page 1 file
Price: $49.95
|
|
Special report: Top Wholesaler Report
In a time when giant drug store, supermarket and mass merchant chains with their own distribution centers shake the retail landscape, the drug wholesaling business is alive and well.
For pharmacy retailers, particularly smaller-scale regional chains and independents without distribution centers, the drug wholesaling industry remains a critical back-end resource. Even big national chains still draw on the industry’s unmatched logistical, distribution and storage prowess to guarantee an uninterrupted inventory pipeline, ensure safety stock and support central-fill dispensing operations.
And employed properly, drug wholesalers more than make up for the additional costs they add to the inventory purchased by retail operators. In this special report, Drug Store News examines the top national and regional wholesalers.
PDF Format 4pages, 1File
Price: $9.99
|
|
Special Report: RX Development Series:VMS
Drug Store News in May hosted the first installment of a new program it is calling its Pharmacy Development Series, which focused on the vitamin, mineral and dietary supplement category. Hosted here, the event brought key insights to retailers regarding the science that supports the business of dietary supplements—a category that has received mounting consumer interest from a number of fronts, including baby boomers looking to extend their lives through proper nutrition, as well as other cost-conscious, healthcare consumers who believe that a dietary supplement taken today can help significantly lower personal healthcare costs tomorrow.
Retailers present included GNC—the lead retailer in the dietary supplement channel—as well as several leading drug and grocery chains, including Longs Drug Stores, Meijer, Rite Aid, Supervalu and Walgreens. What follows is an executive report of the proceedings.
PDF Format, 7pages,1 file
Price: $9.95
|
|
Special Report:Annual 2 Niche Report
In today’s immediate-gratification market of retailing, niche brands aren’t given the opportunity of the slow build that they may have been afforded in decades past—creating an environment that demands concrete success in as little as six months, according to several sales and marketing consultants throughout the industry. But the value of niche is still evident—creating destination drivers that increase foot traffic, as well as the opportunity to increase marketbasket size, with products that often are positioned at a premium price and generate higher margins per ring. And before a niche brand pops, it’s also an opportunity to differentiate a retailer’s product mix from the competitor just across the street.
PDF Format, 27 pages, 1 file
Price: $19.99
|
|
Special Report Annual Report 2008
Like their counterparts in other retail pharmacy channels, the people who run the nation’s national and multiregional drug store chains can point to some recent victories on the policymaking and legislative front as they grapple with economic uncertainty. Nevertheless, the nation’s largest drug store operators are facing growing questions about such issues as store saturation, at least in the near term; increasingly fickle consumers with more choices for pharmacy than ever; the slowdown in blockbuster drug approvals; and the ability of supply-chain management automation and other data-driven inventory efficiencies to continue outpacing shrinking margins at the pharmacy and front end. Skyrocketing gas prices—which ratchet up trucking and inventory shipping costs—and rising import costs, among other global economic concerns, also are roiling the retail sales picture.
PDF Format 48 pages, 1 file
Price: $49.99
|
|
Walgreens Full Throttle
Walgreen Co.’s, the crown jewel of chain drug store retailing, is struggling with a scary economic outlook, an anemic flu season, margin pressures in generic prescription drugs and high labor costs. Despite these challenges, Walgreens remains the fastest-growing pharmacy retailer in construction of new stores, adding 536 new units in fiscal 2007 and pushing past the 6,000-store mark.
PDF Format
Price: $19.99
|
|
Supervalu
With the merger of Albertsons and Supervalu in June 2006, a new giant stood astride the U.S. food and drug marketplace. And with its first year of combined operations behind it, the energized Supervalu and its nearly 200,000 employees are learning to run a new kind of retail entity by weaving together the best elements and scale of diverse retail holdings without sacrificing local market brand identification.
PDF Format
Price: $29.99
|
|
|
|
